City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
Click here to login to Secure Web Site   (authorized users only)  
  
Search results:  48  Clinical trial(s) found  (Page 1 of 2 )
Results per page: 25 50 100 All 1-25 Trials Jump to page:

The following studies are available for Brain and Nervous System Cancer:
COH Protocol Number: 13459 ClinicalTrials.gov Number: NCT01898273

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  Phase 2, Open-Label, Imaging Trial of I-124-CLR1404 in Patients with Newly Diagnosed or Recurrent Glioblastoma

COH Protocol Number: 13418 ClinicalTrials.gov Number: NCT02014844

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  An Open-Label Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of Aldoxorubicin in Subjects with Unresectable Glioblastoma Whose Tumors Have Progressed Following Prior Treatment with Surgery, Radiation and Temozolomide

COH Protocol Number: 13401 ClinicalTrials.gov Number: NCT02015819

Principal Investigator: Jana Portnow, MD
Sponsor: Institutional

Title:  A Phase I Study of Cytosine Deaminase-Expressing Neural Stem Cells in Combination with Oral 5-Fluorocytosine and Leucovorin for the Treatment of Recurrent High-Grade Gliomas

COH Protocol Number: 13384 ClinicalTrials.gov Number: NCT02208362

Principal Investigator: Behnam Badie, MD
Sponsor: Institutional

Title:  Phase I Study of Cellular Immunotherapy Using Central Memory Enriched T Cells Lentivirally Transduced to Express an IL13Ra2-Specific, Hinge-Optimized, 41BB-Costimulatory Chimeric Receptor and a Truncated CD19 for Patients with Recurrent/Refractory Malignant Glioma

COH Protocol Number: 13140 ClinicalTrials.gov Number: NCT01096368

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ACNS0831:Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma ages 1-21 years

COH Protocol Number: 12242

Principal Investigator: Jana Portnow, MD
Sponsor: Institutional

Title:  An Intracerebral Microdialysis Study in Patients with Recurrent High Grade Gliomas Being Treated with TOCA 511 and TOCA FC

COH Protocol Number: 11320 ClinicalTrials.gov Number: NCT01627535

Principal Investigator: Neal Prakash, MD, PhD
Sponsor: Institutional

Title:  Feasibility of Intraoperative Optical Imaging and Spectroscopy in Brain Tumors

COH Protocol Number: 11180 ClinicalTrials.gov Number: NCT00045968

Principal Investigator: Jana Portnow, MD
Sponsor: Industrial

Title:  A Phase III Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

COH Protocol Number: 08138

Principal Investigator: Ellie Maghami, MD
Sponsor: Institutional

Title:  City of Hope Head and Neck Database Using the American Head and Neck Society Otobase

COH Protocol Number: 07185

Principal Investigator: Saro Armenian, DO
Sponsor: NCI Approved External Peer Review

Title:  Childhood Cancer Survivor Study

COH Protocol Number: 07074

Principal Investigator: Christine Brown, PH.D.
Sponsor: Institutional

Title:  Isolation of Brain Tumor Cancer Stem Cells from Discard Primary Glioma Tissue

COH Protocol Number: 02079 ClinicalTrials.gov Number: NCT00026312

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ANBL0032: Phase III Randomized Study Of Chimeric Antibody 14.18 (CH14.18) In High Risk Neuroblastoma Following Myeloablative Therapy And Autologous Stem Cell Rescue

COH Protocol Number: 01094

Principal Investigator: Anna Pawlowska, MD
Sponsor: Cooperative Group

Title:  COG ANBL00B1: Neuroblastoma Biology Studies

The following studies are available for many cancer types, including Brain and Nervous System Cancer:
COH Protocol Number: 15073

Principal Investigator: Saro Armenian, DO
Sponsor: Institutional

Title:  Assessment of Cardiovascular Reserve Capacity in Hematopoietic Cell Transplantation Survivors: a Pilot Feasibility Study

COH Protocol Number: 15025 ClinicalTrials.gov Number: NCT02408406

Principal Investigator: Matthew Loscalzo, MSW
Sponsor: NCI Approved External Peer Review

Title:  PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum

COH Protocol Number: 15005 ClinicalTrials.gov Number: NCT00697632

Principal Investigator: Karen Reckamp, MD
Sponsor: Industrial

Title:  Open-Label, Dose-Escalation Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Daily Oral MGCD265 Administered Without Interruption to Patients with Advanced Malignancies

COH Protocol Number: 14302 ClinicalTrials.gov Number: NCT02345798

Principal Investigator: Jae Kim, MD
Sponsor: Institutional

Title:  Preparing Patients and Informal Caregivers for Lung Surgery: Pilot Study of a Video-Assisted Intervention to Enhance Post-Operative Recovery

COH Protocol Number: 14299 ClinicalTrials.gov Number: NCT02301104

Principal Investigator: Marwan Fakih, MD
Sponsor: Industrial

Title:  A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAS-102 in Patients with Advanced Solid Tumors and Varying Degrees of Hepatic Impairment

COH Protocol Number: 14285 ClinicalTrials.gov Number: NCT02301117

Principal Investigator: Marwan Fakih, MD
Sponsor: Industrial

Title:  A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TAS-102 in Patients with Advanced Solid Tumors and Varying Degrees of Renal Impairment

COH Protocol Number: 14276 ClinicalTrials.gov Number: NCT02243592

Principal Investigator: Robert Chen, MD
Sponsor: NCI Approved External Peer Review

Title:  Exceptional Responders Pilot Study: Molecular Profiling of Tumors from Cancer Patients who are Exceptional Responders

COH Protocol Number: 14265 ClinicalTrials.gov Number: NCT01625234

Principal Investigator: Karen Reckamp, MD
Sponsor: Industrial

Title:  Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer

COH Protocol Number: 14262 ClinicalTrials.gov Number: NCT01004224

Principal Investigator: Sumanta Pal, MD
Sponsor: Industrial

Title:  A Phase I, Open-Label, Multi-Center, Dose Escalation Study of Oral BGJ398, a Pan FGF-R Kinase Inhibitor, in Adult Patients with Advanced Solid Malignancies

COH Protocol Number: 14238 ClinicalTrials.gov Number: NCT02293954

Principal Investigator: Jeffrey Wong, MD
Sponsor: Institutional

Title:  Pilot Study: Detection of Carcinomas Using 64Cu-Labeled M5A Antibody to Carcinoembryonic Antigen (CEA)

COH Protocol Number: 14161 ClinicalTrials.gov Number: NCT02250157

Principal Investigator: Marwan Fakih, MD
Sponsor: Industrial

Title:  A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects with Advanced Malignancies

COH Protocol Number: 14154

Principal Investigator: Saro Armenian, DO
Sponsor: Institutional

Title:  Assessment of a Novel iPhone®-based Platform for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors at Risk for Anthracycline-related Heart Failure

 
Results per page: 25 50 100 All 1-25 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.